HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Vena Cava Filters (Inferior Vena Cava Filter)

Subscribe to New Research on Vena Cava Filters

Mechanical devices inserted in the inferior vena cava that prevent the migration of blood clots from deep venous thrombosis of the leg.

Also Known As:

Inferior Vena Cava Filter; Filter, Inferior Vena Cava; Filters, Inferior Vena Cava; Cava Filter, Vena; Cava Filters, Vena; Filter, Umbrella; Filter, Vena Cava; Filters, Umbrella; Filters, Vena Cava; Umbrella Filter; Vena Cava Filter; Inferior Vena Cava Filters; Umbrella Filters

Networked: 472 relevant articles (43 outcomes, 28 trials/studies) for this Therapy, Comments

Relationship Network

Therapy Context: Research Results

Equipment and Supplies
- Prostheses and Implants: 10106
  - Vena Cava Filters: 472

Experts

1.	Sing, Ronald F: 11 articles (12/2008 - 03/2002)
2.	Heniford, B Todd: 9 articles (12/2008 - 03/2002)
3.	Rosenthal, David: 6 articles (08/2009 - 02/2004)
4.	Wellons, Eric D: 5 articles (08/2009 - 07/2004)
5.	Greenfield, Lazar J: 4 articles (01/2008 - 05/2003)
6.	Kercher, Kent W: 4 articles (12/2006 - 11/2002)
7.	Cohen, Sidney A: 3 articles (08/2008 - 09/2005)
8.	Yamagami, T: 3 articles (05/2008 - 10/2003)
9.	Nishimura, T: 3 articles (05/2008 - 10/2003)
10.	Kaufman, John A: 3 articles (04/2008 - 02/2007)

Related Diseases

1.	Pulmonary Embolism 01/01/2009 - "Retrievable inferior vena cava filters (IVCFs) offer protection against pulmonary embolism during this high-risk period, when anticoagulation is discontinued, while avoiding potential long-term sequelae of a permanent IVCF. " 05/01/2008 - "A retrievable inferior vena cava filter, as an adjunct to chemical and mechanical prophylaxis, was a safe and effective means of reducing the acute risk of pulmonary embolism in this high-risk group of patients. " 11/01/2005 - "CONCLUSION: The OptEase permanent/retrievable vena cava filter can be safely and successfully retrieved up to 14 days in patients who no longer require inferior vena cava filter protection against pulmonary embolism." 07/10/2000 - "CONCLUSIONS: Insertion of a vena cava filter was not associated with a significant reduction in the 1-year incidence of rehospitalization for pulmonary embolism. " 06/01/2006 - "CONCLUSION: The TrapEase vena cava filter is effective in the prevention of pulmonary embolism, with minimal complications." Order ALL the reference details at left...
2.	Venous Thrombosis (Deep-Vein Thrombosis) 07/01/2006 - "The purpose of this study was to evaluate the filtering effect of the Gunther tulip retrievable vena cava filter (GTF) during treatment of deep venous thrombosis (DVT) in the lower extremity using various interventional radiological procedures. " 06/01/1995 - "The use of vena cava filters as primary prophylaxis or therapy for deep vein thrombosis and PE should await the results of controlled trials." 01/01/2009 - "Clinical outcome of perioperative nonpermanent vena cava filter placement in patients with deep venous thrombosis or blood stasis of the vein." 11/01/2008 - "Inferior vena cava filters are considered the therapeutic modality for treatment of deep venous thrombosis in patients who are not candidates for anticoagulation therapy. " 05/01/2008 - "Prophylactic implantation of inferior vena cava filter during endovascular therapies for deep venous thrombosis of the lower extremity: is it necessary?" Order ALL the reference details at left...
3.	Wounds and Injuries (Trauma) 06/01/2005 - "Retrievable vena cava filters may prove beneficial in this subset of trauma patients. " 09/01/1999 - "PURPOSE: The efficacy of prophylactic inferior vena cava filters in selected trauma patients at high risk has come into question in relation to risk/benefit assessment. " 01/01/1997 - "Efficacy of prophylactic vena cava filters in high-risk trauma patients." 01/01/2007 - "Safety and efficacy of vena cava filters in trauma patients." 01/01/2006 - "The results of this study lead us to question the rationale for a more liberal use of vena cava filters in trauma patients." Order ALL the reference details at left...
4.	Thrombosis (Thrombus) 05/01/1995 - "The thrombosis was treated successfully with an inferior vena cava filter." 07/01/2000 - "Thrombosis complicating the course of malignancy may be notoriously difficult to treat, but the introduction of the low-molecular-weight heparins has greatly improved management and may obviate the need for invasive approaches, such as the use of inferior vena cava filters, in many cases. " 03/01/1998 - "In vitro model for the evaluation of inferior vena cava filters: effect of experimental parameters on thrombus-capturing efficacy of the Vena Tech-LGM filter." 02/01/2007 - "This could facilitate standardized reporting of thrombus volumes in studies of optional vena cava filters." 10/01/2002 - "If these studies are used as screening tools, confirmation of the presence of thrombosis with selective venography should be performed prior to initiating invasive treatment with a vena cava filter. " Order ALL the reference details at left...
5.	Venous Thromboembolism 09/01/2009 - "Permanent/retrievable vena cava filters are safe and effective devices for PE prophylaxis and for the management of venous thromboembolism by providing the option to be left in place." 09/01/2008 - "Recent trials have demonstrated the efficacy of short-term insertion of inferior vena cava filters in the treatment and prophylaxis of venous thromboembolism certain populations, especially those with a reversible contraindication to anticoagulation. " 11/01/2005 - "PURPOSE: To evaluate the success, safety, and efficacy of the retrieval of the OptEase Permanent/Retrievable Vena Cava Filter (Cordis, Warren, NJ), when implanted for temporary protection against venous thromboembolism. " 01/01/2007 - "A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism." 07/10/2000 - "A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Streptokinase
2.	coumarin
3.	Heparin (Liquaemin)
4.	EVAC protocol (CAVE)
5.	Anticoagulants
6.	Anti-Bacterial Agents (Antibiotics)
7.	nitinol
8.	Warfarin (Coumadin)
9.	Titanium
10.	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)

Related Therapies and Procedures

1.	Thrombolytic Therapy
2.	Vena Cava Filters (Inferior Vena Cava Filter)
3.	Embolectomy
4.	Arthroplasty
5.	Hysterectomy

blog comments powered by Disqus

TREATMENT OPTIONS
for Pulmonary Embolism,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 305 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>